This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (42)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Penny Albright, PhD; Joseph Bruni, MD, FRCP(C)

Arch Neurol. 1985;42(8):797-799.

Abstract
• An attempt was made to reduce polypharmacy in 90 epileptic patients. All patients received their original drug regimen for at least six months and were followed up for a minimum of 16 months after reduction of polypharmacy. In 72 patients (80%), the average number of drugs administered was reduced from 2.75 to 1.49. In 39 of these (54%), a reduction was made to single drug therapy. Either no change or an improvement in seizure control was observed, and side effects decreased in many patients. In 18 patients (20%), medications could not be withdrawn. In nine of these, another drug was required for seizure control. In the remaining nine, more frequent seizures necessitated a return to the previous regimen. The critical variable predictng unsuccessful reduction of polypharmacy was the presence of multiple concurrent seizure types.

Author Affiliations
From the University of Toronto and Wellesley Hospital, Toronto. Dr Albright is a Fellow of the Medical Research Council of Canada.

Footnotes
Accepted for publication Oct 1, 1984.

Read at the 15th Epilepsy International Symposium and American Epilepsy Society meeting, Washington, DC, Sept 28, 1983.

Reprint requests to Room 318, E. K. Jones Building, Wellesley Hospital, 160 Wellesley St E, Toronto, Ontario, Canada M4Y 1J3 (Dr Bruni).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?